How common is hemolytic disease of the newborn?

Many people may not have heard of hemolytic disease of the newborn (HDN), which is primarily caused by blood type incompatibility between the fetus and the mother. How common is hemolytic disease of the newborn?

How Common Is Hemolytic Disease of the Newborn?

The incidence of hemolytic disease of the newborn is relatively low, generally occurring in 2% to 5% of births. This condition mainly results from blood type incompatibility between the fetus and the mother. Clinically, two types are recognized: ABO incompatibility and Rh incompatibility. Affected newborns typically present with severe jaundice, and bilirubin levels rise rapidly after birth. In severe cases, this can lead to kernicterus (high bilirubin encephalopathy) and brain damage in newborns.

After birth, newborns should be examined promptly to monitor for signs of jaundice and to determine their blood type. By combining information about bilirubin levels with knowledge of maternal and infant blood types, doctors can accurately assess whether hemolytic disease is present. If HDN is confirmed and jaundice worsens, treatments such as phototherapy or medication must be administered. In some cases, a blood exchange transfusion may also be necessary.

To prevent hemolytic disease of the newborn, prenatal interventions such as early delivery, plasma exchange, intrauterine blood transfusions, and prophylactic use of phenobarbital may be used to reduce neonatal jaundice. During pregnancy, it's important to maintain a positive mood and attend regular prenatal checkups. Diet-wise, consume more foods rich in high-quality protein and vitamins, and avoid spicy or irritating foods. We hope this information has been helpful. Wishing you good health and happiness!